Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to Amphotericin B and Miconazole

BioMetals

Volumn 17, Issue 4, 2004, Pages 415-422

  Eshwika, Ahmed ^a   Coyle, Barry ^a   Devereux, Michael ^b   McCann, Malachy ^a   Kavanagh, Kevin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; AMPHOTERICIN B; COPPER COMPLEX; ERGOSTEROL; METAL COMPLEX; MICONAZOLE; SILVER DERIVATIVE;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS GROWTH; LIPOGENESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXYGEN CONSUMPTION;

AMPHOTERICIN B; CANDIDA ALBICANS; CELL RESPIRATION; COPPER; ERGOSTEROL; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; OXYGEN; OXYGEN CONSUMPTION; PHENANTHROLINES; SILVER; SPECTRUM ANALYSIS;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 3042843862     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BIOM.0000029438.97990.c6     Document Type: Article

References (17)

1. Abu-Salah KM. 1996 Amphotericin B: an update. Brit J Biomed Sci 53, 122-133.
2. Arthington-Skaggs BA, Warnock DW, Morrison CJ. 1999 Quantitation of ergosterol content: Novel methods for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37, 3332-3337.
3. Canuto M, Rodero FG. 2002 Antifungal drug resistance to azole and polyenes. Lancet (Infect Dis) 2, 550-562.
4. Coyle B, Kavanagh K, McCann M, Devereux M, Geraghty M. 2003a Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes. Biometals 16, 321-329.
5. Coyle B, Kinsella P, McCann M, Devereux M, O'Connor R, Clynes M, Kavanagh K. 2003b Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicology in Vitro (in press).
6. Daum G, Lees ND, Bard M, Dickson R. 1998 Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast 14, 1471-1510.
7. Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, Bennett JE. 1995 Deletion of the Candida glabrata ERG3 and ERG11 genes: Effect on cell viability, cell growth, sterol composition and antifungal susceptibility. Antimicrob Agen Chemother 39, 2708-2717.
8. Geraghty P. Kavanagh K. 2003a Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the Amphotericin B susceptibility of Candida albicans. J Pharm Pharmacol 55, 179-184.
9. Geraghty P, Kavanagh K. 2003b Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of Amphotericin B. Arch Microbiol 179, 295-300.
10. Igdaloff D, Santi DV, Eckert TS, Bruice TC. 1983. Effects of 1,7-and 1,10-phenanthroline dione on tissue culture cells. Biochemical Pharmacol 32, 172-174.
11. 5,6 desaturation. FEBS Letts 400, 80-82.
12. McCann M, Geraghty M, Devereux M et al. 2000 Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates. Metal-Based Drugs 7, 185-193.
13. 4 (phendio = 1,10-phenanthroline-5,6- dione) and its effects on fungal and mammalian cells. Biometals (submitted).
14. Morschhauser J. 2002 The genetic basis of fluconazole resistance development in Candida albicans. Biochem Biophys Acta 1587, 240-248.
15. Parks LW, Casey WM. 1995 Physiological implications of sterol biosynthesis in yeast. Ann Rev Microbial 49, 95-116.
16. Vazquez JA, Arganoza MT, Vaishampayan JK, Akins RA. 1996 In vitro interaction between Amphotercin B and azoles in Candida albicans. Antinticrob Agen Chemother 40: 2511-2516.
17. White TC, Marr KA, Bowden RA. 1998 Clinical, cellular and molecular factors that contribute to anti-fungal drug resistance. Clin Microbiol Rev 11: 382-402.